Relay Therapeutics Inc (RLAY) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Relay Therapeutics Inc   (NASDAQ: RLAY)

Relay Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RLAY Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 71.11 % 65.43 % 46.05 %
Gross Margin (Q2 TTM) 96.62 % 79.56 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 70.97 % 64.67 % 47.07 %
EBITDA Margin (Q2 MRQ) 102.86 % 20.59 % 19.62 % 20.6 %
EBITDA Margin (Q2 TTM) -2102.5 % 27.11 % 20.88 % 19.1 %
EBITDA Margin 5 Yr. Avg. --5924.95 % 22.77 % 31.17 % 22.07 %
Operating Margin (Q2 MRQ) -25949.71 % 11.28 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) -2999.67 % 16.53 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. --6005.74 % 6.03 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 7.4 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) -1955.07 % 15.08 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.45 % 12.49 %
Net Margin (Q2 MRQ) -23916.29 % 2.64 % 8.14 % 11.41 %
Net Margin (Q2 TTM) -2763.91 % 11.11 % 9.99 % 10.75 %
Net Margin 5 Yr. Avg. - 6.58 % 6.23 % 9.95 %



Business Segment Profit Margin
 
Revenue Abstract
  Explore Revenue Abstract Segment  -